Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
J Hosp Infect ; 99(3): 295-298, 2018 Jul.
Article in English | MEDLINE | ID: mdl-29501730

ABSTRACT

Few studies have used molecular epidemiological methods to study transmission links to clinical isolates in intensive care units. Ninety-four multidrug-resistant organisms (MDROs) cultured from routine specimens from intensive care unit (ICU) patients over 13 weeks were stored (11 meticillin-resistant Staphylococcus aureus (MRSA), two vancomycin-resistant enterococci and 81 Gram-negative bacteria). Medical staff personal mobile phones, departmental phones, and ICU keyboards were swabbed and cultured for MDROs; MRSA was isolated from two phones. Environmental and patient isolates of the same genus were selected for whole genome sequencing. On whole genome sequencing, the mobile phone isolates had a pairwise single nucleotide polymorphism (SNP) distance of 183. However, >15,000 core genome SNPs separated the mobile phone and clinical isolates. In a low-endemic setting, mobile phones and keyboards appear unlikely to contribute to hospital-acquired MDROs.


Subject(s)
Cell Phone , Computers , Cross Infection/microbiology , Environmental Microbiology , Gram-Negative Bacteria/isolation & purification , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Vancomycin-Resistant Enterococci/isolation & purification , Cross Infection/epidemiology , Disease Transmission, Infectious , Genotype , Gram-Negative Bacteria/classification , Gram-Negative Bacteria/genetics , Humans , Intensive Care Units , Methicillin-Resistant Staphylococcus aureus/classification , Methicillin-Resistant Staphylococcus aureus/genetics , Molecular Epidemiology , Polymorphism, Single Nucleotide , Tertiary Care Centers , Vancomycin-Resistant Enterococci/classification , Vancomycin-Resistant Enterococci/genetics , Whole Genome Sequencing
3.
Br J Dermatol ; 177(5): 1234-1247, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28256714

ABSTRACT

Severe cutaneous adverse reactions (SCARs) encompass a heterogeneous group of delayed hypersensitivity reactions, which are most frequently caused by drugs. Our understanding of several aspects of SCAR syndromes has evolved considerably over the last decade. This review explores evolving knowledge of the immunopathogenic mechanisms, pharmacogenomic associations, in vivo and ex vivo diagnostics for causality assessment, and medication cross-reactivity data related to SCAR syndromes. Given the rarity and severity of these diseases, multidisciplinary collaboration through large international, national and/or multicentre networks to collect prospective data on patients with SCAR syndromes should be prioritized. This will further enhance a systematized framework for translating epidemiological, clinical and immunopathogenetic advances into preventive efforts and improved outcomes for patients.


Subject(s)
Drug Eruptions/etiology , Allopurinol/adverse effects , Anticonvulsants/adverse effects , Carbamazepine/adverse effects , Cephalosporins/adverse effects , Dideoxynucleosides/adverse effects , Drug Eruptions/diagnosis , Drug Eruptions/immunology , Drug Interactions , Herpesviridae Infections/chemically induced , Humans , Leukocytes, Mononuclear/immunology , Pharmacogenetics/trends , Prospective Studies , Skin Tests/methods , T-Lymphocytes/immunology , Virus Activation/drug effects , Virus Latency/drug effects , beta-Lactams/adverse effects
4.
Clin Exp Dermatol ; 42(3): 299-302, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28084616

ABSTRACT

Linear IgA bullous dermatosis (LABD) is a subepidermal autoimmune bullous disease characterized by linear IgA deposition at the basement membrane zone, which is visualized by direct immunofluorescence. Patients with LABD typically present with widespread vesicles and bullae; however, this is not necessarily the case, as the clinical presentation of this disease is heterogeneous. LABD clinically presenting as Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN) is an infrequent, yet well-described phenomenon. Most cases of LABD are idiopathic, but some cases are drug-induced. Multiple drugs have been implicated in the development of LABD. We report a case of piperacillin-tazobactam-induced LABD presenting clinically as SJS/TEN overlap. This is the first reported case of a strong causal association between piperacillin-tazobactam and the development of LABD.


Subject(s)
Anti-Bacterial Agents/adverse effects , Linear IgA Bullous Dermatosis/chemically induced , Penicillanic Acid/analogs & derivatives , Stevens-Johnson Syndrome/diagnosis , Diagnosis, Differential , Humans , Male , Middle Aged , Penicillanic Acid/adverse effects , Piperacillin/adverse effects , Piperacillin, Tazobactam Drug Combination
7.
Travel Med Infect Dis ; 13(1): 31-47, 2015.
Article in English | MEDLINE | ID: mdl-25593039

ABSTRACT

International travellers with immunocompromising conditions such as human immunodeficiency virus (HIV) infection, solid organ transplantation (SOT) and haematopoietic stem cell transplantation (HSCT) are at a significant risk of travel-related illnesses from both communicable and non-communicable diseases, depending on the intensity of underlying immune dysfunction, travel destinations and activities. In addition, the choice of travel vaccinations, timing and protective antibody responses are also highly dependent on the underlying conditions and thus pose significant challenges to the health-care providers who are involved in pre-travel risk assessment. This review article provides a framework of understanding and approach to aforementioned groups of immunocompromised travellers regarding pre-travel risk assessment and management; in particular travel vaccinations, infectious and non-infectious disease risks and provision of condition-specific advice; to reduce travel-related mortality and morbidity.


Subject(s)
Communicable Disease Control , Immunocompromised Host , Transplant Recipients , Travel , Vaccination , HIV Infections/immunology , Hematopoietic Stem Cell Transplantation , Hematopoietic Stem Cells , Humans , Organ Transplantation , Pre-Exposure Prophylaxis , Risk Assessment
8.
New Microbes New Infect ; 1(2): 32-3, 2013 Nov.
Article in English | MEDLINE | ID: mdl-25356325

ABSTRACT

We report the first case of fatal spontaneous bacterial peritonitis and fulminant hepatitis caused by Nocardia cyriacigeorgica in a patient with hepatitis C-related liver cirrhosis.

9.
J Hum Evol ; 40(5): 393-409, 2001 May.
Article in English | MEDLINE | ID: mdl-11322801

ABSTRACT

A new genus and species of medium-sized fossil primate, Myanmarpithecus yarshensis, is described from the lastest middle Eocene sediments of Pondaung, central Myanmar (Burma). The specimens consist of right maxillary fragments with P(4)-M(3)and a left mandibular corpus with C-P(3)and M(2-3). To date, three purported anthropoids have been discovered from the Pondaung Formation: Pondaungia and Amphipithecus (Amphipithecidae) and Bahinia (Eosimiidae). Myanmarpithecus differs from these other Pondaung primates in having cingular hypocones on upper molars and in lacking paraconids on M(2-3). Although Myanmarpithecus resembles some utahiin omomyines in superficial aspects of the morphology of M(2-3)(i.e., mesiodistally compressed molar trigonid and enamel crenulation), the morphological analysis of upper molars and lower premolars indicates that it is neither an omomyoid nor an adapoid but is more derived than fossil prosimians (such as adapoids, omomyoids, and tarsiers) and more anthropoid-like. On the other hand, it is more primitive (prosimian-like) than early anthropoids from the late Eocene/early Oligocene of the Fayum, Egypt. Myanmarpithecus is likely to be an early, primitive anthropoid ("protoanthropoid").


Subject(s)
Fossils , Haplorhini/classification , Animals , Anthropology, Physical , Egypt , Mandible/physiology , Microscopy, Electron, Scanning , Molar/physiology , Myanmar , Paleontology/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...